MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fphar.2024.1440523

Медицинская библиотека · Frontiers in pharmacology · 2024

Pharmacogenetics testing for poor response to antidepressants: a transnosographic case series.

Lorvellec Marie-Agnès, Sipahimalani Gilles, Lahutte Bertrand, Delacour Hervé, Baldacci Antoine, Saguin Emeric

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Pharmacogenetics (PGx) holds promise for optimizing psychotropic medication use, with CYP2D6 and CYP2C19 identified as key genes in antidepressant treatment. However, few studies have explored the genetic variants of these genes in real-world settings for patients experiencing ineffectiveness or adverse drug reactions (ADRs) to antidepressants.

METHODS

This case series includes 40 patients who underwent PGx testing due to antidepressant ineffectiveness or ADRs between June 2020 and April 2022. We describe the patients' demographic, clinical, and genetic characteristics and assess the value of PGx testing based on feedback from their psychiatrists.

RESULTS

The most common diagnoses were major depressive disorder (60.0%) and post-traumatic stress disorder (30.0%). Ineffectiveness was reported in 65.0% of patients, ADRs in 2.5%, and both in 32.5%. The antidepressants involved included SSRIs (45.0%), SNRIs (27.5%), atypical antidepressants (20.0%), and tricyclics (17.5%). Only 17.5% of patients had normal CYP2D6 and CYP2C19 metabolic activity. Actionable genetic variants were identified in 22.0% of CYP2D6/CYP2C19-antidepressant-response pairs. PGx recommendations were followed in 92.7% of cases, with significant improvement in ADRs reported in 71.4% of patients and efficacy improvement in 79.5%.

DISCUSSION: Our findings suggest that PGx testing can guide prescribing decisions for patients with antidepressant ineffectiveness or ADRs. The relatively high prevalence of genetic variants affecting pharmacokinetics supports the broader adoption of PGx testing in psychiatric practice.

Для цитирования: Lorvellec Marie-Agnès, Sipahimalani Gilles, Lahutte Bertrand, Delacour Hervé, Baldacci Antoine, Saguin Emeric. Pharmacogenetics testing for poor response to antidepressants: a transnosographic case series.. Frontiers in pharmacology. 2024. DOI: 10.3389/fphar.2024.1440523.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.